Cardiovascular Therapeutics

期刊基本信息

  • 期刊名称:Cardiovascular Therapeutics
  • 期刊级别: Science Citation Index Expanded (SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ)
  • 期刊ISSN:1755-5914
  • 期刊EISSN:1755-5922
  • 简称:CARDIOVASC THER
  • 影响因子:3.4
  • 实时影响因子:截止2025年5月19日:3.317
  • 五年影响因子:3.3
  • JCI期刊引文指标:0.84
  • h-index:39
  • 2024-2025自引率:2.90%
  • 期刊官方网站:期刊官方网站
  • 期刊投稿网址:https://mc.manuscriptcentral.com/cdr
  • 是否OA开放访问:No
  • 出版商:Wiley-Blackwell Publishing Ltd
  • 出版年份:2008

Cardiovascular Therapeutics

Science Citation Index Expanded (SCIE)Scopus (CiteScore)Directory of Open Access Journals (DOAJ)

期刊介绍

Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged.

Subject areas include (but are by no means limited to):

Acute coronary syndrome
Arrhythmias
Atherosclerosis
Basic cardiac electrophysiology
Cardiac catheterization
Cardiac remodeling
Coagulation and thrombosis
Diabetic cardiovascular disease
Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF)
Hyperlipidemia
Hypertension
Ischemic heart disease
Vascular biology
Ventricular assist devices
Molecular cardio-biology
Myocardial regeneration
Lipoprotein metabolism
Radial artery access
Percutaneous coronary intervention
Transcatheter aortic and mitral valve replacement.

期刊语言要求

Language
Manuscripts must be written in American English and be grammatically and linguistically correct. Authors should seek assistance with style, grammar and vocabulary if necessary. Your manuscript may also be sent back to you for revision if the quality of English language is poor.

投稿要求

  • 通讯方式:WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148
  • 涉及的研究方向:医学-心血管系统
  • 出版国家或地区:UNITED STATES
  • 出版语言:English
  • 年文章数:33
  • PubMed Central (PMC)链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1755-5914%5BISSN%5D
  • 平均录用比例:约95%

CITESCORE

CiteScoreSJRSNIPCiteScore排名
5.800.8310.945
学科分区排名百分位
大类:Medicine
小类:Cardiology and Cardiovascular Medicine
Q194 / 397
76%
大类:Medicine
小类:Pharmacology (medical)
Q275 / 275
72%
大类:Medicine
小类:Pharmacology
Q2111 / 321
65%

WOS期刊JCR分区

WOS分区等级:2区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:CARDIAC & CARDIOVASCULAR SYSTEMSSCIEQ262/230
73.3%
学科:PHARMACOLOGY & PHARMACYSCIEQ2113/352
68%
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:CARDIAC & CARDIOVASCULAR SYSTEMSSCIEQ267/230
71.09%
学科:PHARMACOLOGY & PHARMACYSCIEQ2107/353
69.83%

期刊分区表预警名单

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中

中科院2025年3月升级版

点击查看中国科学院期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区3区4区
CARDIAC & CARDIOVASCULAR SYSTEMS
心脏和心血管系统
2区3区3区
PHARMACOLOGY & PHARMACY
药学
1区3区3区

中科院2023年12月旧的升级版

大类学科小类学科Top期刊综述期刊
医学 4区4区2区
PHARMACOLOGY & PHARMACY
药学
3区1区3区
CARDIAC & CARDIOVASCULAR SYSTEMS
心脏和心血管系统
4区4区4区

联系我们

QQ:1211130760

微信:iqkan555

微信扫码加好友 微信扫码加好友
QQ扫码加好友 QQ扫码加好友